CIT and rheumatoid arthritis: We found At-Risk participants to have a significantly higher frequency of cit-specific T cells than anti-CCP3(−) Controls; in addition, the frequency of cit-specific T cells was similar between At-Risk and Early RA participants (Fig. 2a).